01677nam a2200397 i 4500001001300000003000300013005001700016007001400033008004100047040003000088041000800118042000800126043001200134050002000146074001600166086002000182110008200202245007800284264007100362300002300433336000800456337001600464338001900480490007700499500002500576500003600601500002500637533010600662588001900768650005000787650006300837655003400900776014300934776014401077810005801221ocn988750204BD20171204220929.0he bmb024bbca170602s2016    dcu     b    f000 0 eng c  aPUCPRbengerdacGPOdMvI  aspa  apcc  an-us---14aKF32b.E55 2016  a1008-D (MF)0 aY 1.1/8:114-8011 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce,eauthor.10aNational Clinical Care Commission Act :breport (to accompany H.R. 1192). 1a[Washington, D.C.] :b[U.S. Government Publishing Office],c[2016]  a10 pages ;c24 cm.  btxt  bh2rdamedia  bhe2rdacarrier1 aReport / 114th Congress, 2d session, House of Representatives ;v114-801  a"November 14, 2016."  aShipping list no.: 2017-0006-M.  aCRDP Program record.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2016]e1 microfiche : negative.  aCaption title. 0aDiabetesxLaw and legislationzUnited States. 0aMetabolismxDisordersxLaw and legislationzUnited States. 7aLegislative materials.2lcgft08iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce.tNational Clinical Care Commission Actw(OCoLC)96445214808iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce.tNational Clinical Care Commission Actw(OCoLC)9638580581 aUnited States.bCongress.bHouse.tReport ;v114-801.